Meeting report from the Prostate Cancer Foundation PSMA theranostics state of the science meeting.

ABSTRACT:

Introduction

The Prostate Cancer Foundation (PCF) convened a PCF prostate-specific membrane antigen (PSMA) Theranostics State of the Science Meeting on 18 November 2019, at Weill Cornell Medicine, New York, NY.

Methods

The meeting was attended by 22 basic, translational, and clinical researchers from around the globe, with expertise in PSMA biology, development and use of PSMA theranostics agents, and clinical trials. The goal of this meeting was to discuss the current state of knowledge, the most important biological and clinical questions, and critical next steps for the clinical development of PSMA positron emission tomography (PET) imaging agents and PSMA-targeted radionuclide agents for patients with prostate cancer.

Results

Several major topic areas were discuss

SUBMITTER: Miyahira AK 

PROVIDER: S-EPMC8442561 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature